Xia Xue, Wei Ya, Huang Qianqian, Zhou Yang, Wang Xiaorong, Shi Yulong, Yang Xiaotong, Yang Wenqin, Zhang Yiwei, Lei Ting, Huang Yuan, Li Hanmei, Qin Meng, Gao Huile
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, West China School of Pharmacy, Mental Health Center and National Chengdu Center for Safety Evaluation of Drugs, West China Hospital, Sichuan University, Chengdu 610041, China.
Key Laboratory of Coarse Cereal Processing, School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Acta Pharm Sin B. 2024 Dec;14(12):5464-5478. doi: 10.1016/j.apsb.2024.05.017. Epub 2024 May 22.
The neurovascular unit (NVU) is highly responsible for cerebral homeostasis and its dysfunction emerges as a critical contributor to Alzheimer's disease (AD) pathology. Hence, rescuing NVU dysfunction might be a viable approach to AD treatments. Here, we fabricated a self-regulated muti-functional nano-modulator (siR/PIO@RP) that can intelligently navigate to damaged blood-brain barrier and release therapeutical cargoes for synergetic AD therapy. The resulting siR/PIO@RP enables self-regulation of its distribution in accordance with the physio/pathological state (low/high RAGE expression) of the target site a feedback loop. siR/PIO@RP is capable of performing intricate tasks and goes beyond the capabilities of single-target therapeutic agents utilized in AD therapy, such as reducing cerebral A load, relieving neuroinflammation, and alleviating the dysfunction of NVU. Overall, the current study provides proof of concept that normalizing NVU holds promise as a means of alleviating AD symptoms.
神经血管单元(NVU)对大脑内环境稳态高度负责,其功能障碍是阿尔茨海默病(AD)病理的关键促成因素。因此,挽救NVU功能障碍可能是一种可行的AD治疗方法。在此,我们制备了一种自我调节的多功能纳米调节剂(siR/PIO@RP),它能够智能地靶向受损的血脑屏障并释放治疗性货物以进行协同AD治疗。所得的siR/PIO@RP能够根据靶位点的生理/病理状态(低/高RAGE表达)实现其分布的自我调节——一个反馈回路。siR/PIO@RP能够执行复杂的任务,超越了AD治疗中使用的单一靶点治疗剂的能力,例如减少脑内Aβ负荷、减轻神经炎症以及缓解NVU功能障碍。总体而言,当前研究提供了概念验证,即恢复NVU正常功能有望成为缓解AD症状的一种手段。